Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 785
Ph III recruiting: 82
Growth YoY: +24.3%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 401–450 of 671 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03979573	Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer(PROMM-AS)	unknown	N/A	90	Heinrich-Heine University, DuesseldorfOTHER	1	Jun 7, 2019	clinicaltrials
NCT03960788	Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer	unknown	Early Phase 1	50	University of CincinnatiOTHER	1	May 23, 2019